May 2010
Selectivity of N-Aroyl-N0-arylthioureas towards
2-(1,3-Dioxo-1H-inden-2(3H)-ylidene)malononitrile
507
105.2 (C-11), 70.8 (C-5a), 55.4 (OCH3), 53.2 (C-5). MS (70
eV): m/z (%) ¼ 478 [Mþ] (24), 451 (20), 387 (13), 285 (20),
119 (100), 91 (32), 65 (14). Anal. Calcd. for C27H18N4O3S
(478.52): C, 67.77; H, 3.79; N, 11.71; S, 6.70. Found: C,
67.97; H, 3.70; N, 11.79; S, 6.85.
(Z)-N-(E)-4-Amino-5-cyano-1-(4-metoxylphenyl)-6-oxo-1H-
indeno[1,2-d][1,3]thiazepin-2(6H)-ylidene)-4-methylbenzamide
(3d). Yellowish white crystals (DMF/H2O, 10:1), yield ¼ 404
mg, (82%), m.p. 278–280ꢁC. IR (KBr): 3296, 3132 (m, NH2),
3048–3011 (m, Ar-CH), 2992–2914 (m, aliph.-CH), 2212 (s,
CN), 1731, 1670 (s, C¼¼O), 1645, 1605 (s, C¼¼N). 1H NMR:
8.21 (bs, 2H; NH2), 7.98 (d, J ¼ 8.5, 1H; H-7), 7.78 (t, J ¼
6.7, 2H; H-8,9), 7.72 (d, J ¼ 8.0, 2H; H-20), 7.35 (bs, 2H; H-
200), 7.21 (d, J ¼ 8.0, 2H; H-30), 7.16 (d, J ¼ 8.2, 2H; H-300),
6.65 (d, J ¼ 5.1, 1H; H-10), 3.89 (s, 3H; OCH3), 2.31 (s, 3H;
CACH3). 13C NMR: dC 193.4 (C-6), 175.2 (benzamide C¼¼O),
170.3 (C-2), 165.9 (C-4), 159.6 (C-400), 143.6 (C-40), 143.2 (C-
10a), 136.5 (C-9), 133.4 (C-6a), 132.5 (C-8), 132.3 (C-100),
130.7 (C-200), 129.3 (C-20), 129.0 (C-30), 128.7 (C-10), 125.4 (C-
7), 125.1 (C-10), 116.0 (C-300), 114.5 (CN), 105.4 (C-11), 70.5
(C-5a), 55.5 (OCH3), 53.2 (C-5), 21.1 (CACH3). MS (70 eV):
m/z (%) ¼ 492 [Mþ] (25), 465 (10), 342 (12), 300 (18), 266
(14), 208 (12), 183 (20), 165 (36), 119 (100), 91 (34), 65 (12).
Anal. Calcd. for C28H20N4O3S (492.55): C, 68.28; H, 4.09; N,
11.37; S, 6.51. Found: C, 68.00; H, 4.12; N, 11.20; S, 6.45.
(Z)-N-(E)-4-amino-5-cyano-1-(4-iodophenyl)-6-oxo-1H-
indeno[1,2-d][1,3]thiazepin-2(6H)-ylidene)-4-methylbenzamide
(3e). Yellowish white crystals (ethyl acetate), yield ¼ 412 mg
(70%), m.p. 294–295ꢁC. IR (KBr): 3275, 3150 (m, NH2),
3063–3013 (m, Ar-CH), 2988–2917 (m, aliph.-CH), 2202 (s,
CN), 1732, 1669 (s, C¼¼O), 1643, 1605 (s, C¼¼N). 1H NMR:
8.22 (bs, 2H; NH2), 7.99 (d, J ¼ 8.2, 2H; H-200), 7.98–7.94
(m, 1H; H-7), 7.76–7.72 (m, 2H; H-8,9), 7.69 (d, J ¼ 7.7, 2H;
H-20), 7.28 (d, J ¼ 7.6, 2H; H-300), 7.21 (d, J ¼ 7.7, 2H; H-
30), 6.69–6.65 (m, 1H; H-10), 2.31 (s, 3H; CACH3). 13C
NMR: 193.2 (C-6), 175.2 (benzamide C¼¼O), 170.2 (C-2),
165.9 (C-4), 143.4 (C-10a), 143.3 (C-40), 138.3 (C-200), 136.6
(C-9), 136.1 (C-100), 133.4 (C-6a), 132.6 (C-10), 132.2 (C-8),
131.5 (C-300), 129.3 (C-20), 129.0 (C-30), 125.5 (C-7), 125.0
(C-10), 115.9 (CN), 105.0 (C-11), 96.2 (C-400), 70.9 (C-5a),
53.1 (C-5), 21.2 (CACH3). MS (70 eV): m/z (%) ¼ 588 [Mþ]
(12), 119 (100), 91 (12), 65 (11). Anal. Calcd. for
C27H17IN4O2S (588.42): C, 55.11; H, 2.91; N, 9.52; S, 5.45.
Found: C, 55.24; H, 2.88; N, 9.28; S, 5.30.
Figure 5. The antioxidant activity of 3b, 3c, and 3d was investigated
using DPPH assay. The results are represented as SC50 values (lM) as
(Mean6 S.E, n ¼ 4).
C¼¼O), 1649, 1602 (s, C¼¼N). 1H NMR: 8.21 (bs, 2H; NH2),
7.97 (dd, J ¼ 6.8, 1.6, 1H; H-7), 7.92–7.29 (m, 10H; Ar-H),
6.63 (d, J ¼ 6.5, 1H; H-10). 13C NMR: 193.2 (C-6), 175.3
(benzamide C¼¼O), 170.3 (C-2), 165.7 (C-4), 142.9 (C-10a),
136.7 (C-40), 136.2 (C-9), 134.7 (C-10), 134 (C-100), 133.5 (C-
6a), 131.8 (C-8), 129.9 (C-20), 128.7 (C-30), 127.6 (C-300),
125.5 (C-7), 125.4 (C-10), 125.1 (C-200), 124.6 (C-400), 116.3
(CN), 104.9 (C-11), 70.9 (C-5a), 54.1 (C-5). FAB MS: m/z
(%)
¼
448 [Mþ] (22). Anal. Calcd. for C26H16N4O2S
(448.10): C, 69.63; H, 3.60; N, 12.49; S, 7.15. Found: C,
69.79; H, 3.49; N, 12.52; S, 7.28.
(Z)-N-(E)-4-Amino-5-cyano-1-(4-methylphenyl)-6-oxo-1H-
indeno[1,2-d][1,3]thiazepin-2(6H)-ylidene)-4-methylbenzamide
(3b). Yellowish white crystals (DMF/H2O, 10:1), yield ¼ 381
mg (80%), m.p. 271–272ꢁC. IR (KBr): 3295, 3120 (w, m, NH2),
3070–3000 (m, Ar-CH), 2990–2910 (m, aliph.-CH), 2210 (s,
CN), 1733, 1669 (s, s, C¼¼O), 1645, 1608 (s, s, C¼¼N). 1H
NMR: 8.22 (bs, 2H; NH2), 7.98 (dd, J ¼ 6.6, 1.4, 1H; H-7),
7.75 (t, J ¼ 5.7, 2H; H-8,9), 7.7 (d, J ¼ 8.1, 2H; H-20), 7.43 (d,
J ¼ 8.2, 2H; H-300), 7.33 (bd, J ¼ 7.2, 2H; H-200), 7.19 (d, J ¼
8.0, 2H; H-30), 6.61 (d, J ¼ 6.8, 1H; H-10), 2.47 (s, 3H; H-4a00),
2.3 (s, 3H; H-4a0). 13C NMR: 193.4 (C-6), 175.2 (benzamide
C¼¼O), 170.1 (C-2), 165.9 (C-4), 143.6 (C-10a), 143.2 (C-40),
139.1(C-400), 136.5 (C-9), 133.7 (C-100), 133.3 (C-6a), 132.6 (C-
10), 132.3 (C-8), 129.9 (C-300), 129.2 (C-20), 129.1 (C-200), 129.0
(C-30), 125.4 (C-7), 125.0 (C-10), 116.0 (CN), 105.3 (C-11),
70.6 (C-5a), 53.2 (C-5), 21.1 (C-4a0), 20.9 (C-4a00). MS (70 eV):
m/z (%) ¼ 476 [Mþ] (24), 449 (23), 342 (14), 284 (12), 183
(10), 149 (20), 119 (100), 91 (40), 65 (18). Anal. Calcd. for
C28H20N4O2S (476.55): C, 70.57; H, 4.23; N, 11.76; S, 6.73.
Found: C, 70.69; H, 4.29; N, 11.52; S, 6.58.
(Z)-N-(E)-4-Amino-5-cyano-6-oxo-1-phenyl-1H-indeno[1,2-
d][1,3]thiazepin-2(6H)-ylidene)-4-methoxybenzamide (3c).
Yellowish white crystals (acetone), yield ¼ 407 mg, (85%),
m.p. 270–271ꢁC. IR (KBr): 3350, 3150 (w, NH2), 3050–3013
(m, Ar-CH), 2996–2923 (m, aliph.-CH), 2200 (s, CN), 1727,
1665 (s, C¼¼O), 1608 (s, C¼¼N). 1H NMR: 8.22 (bs, 2H;
NH2), 7.97 (d, J ¼ 7.4, 1H; H-7), 7.75 (d, J ¼ 8.4, 2H; H-20),
7.71–7.68 (m, 2H; H-8,9), 7.63 (bs, 3H; H-300,400), 7.45 (bs,
2H; H-200), 6.91 (d, J ¼ 8.7, 2H; H-30), 6.57 (d, J ¼ 7.5, 1H;
H-10), 3.77 (s, 3H; OCH3). 13C NMR: 193.4 (C-6), 174.6
(benzamide C¼¼O), 169.6 (C-2), 165.9 (C-4), 163 (C-40), 143.5
(C-10a), 136.5 (C-9), 136.4 (C-100), 133.5 (C-6a), 132.6 (C-20),
131.4 (C-8), 129.6 (C-200), 129.5 (C-400), 129.4 (C-300), 127.4
(C-10), 125.4 (C-7), 125.0 (C-10), 116.0 (CN), 113.7 (C-30),
Biological section
Cell culture. Human hepatocellular carcinoma (HepG2) cells
were routinely cultured in Dulbeco’s Modified Eagle’s Medium.
Media were supplemented with 10% fetal bovine serum, 2 mM
L-glutamine, containing 100 units/mL penicillin G sodium, 100
units/mL streptomycin sulphate, and 250 ng/mL amphotericin B.
Cells were maintained at subconfluency at 37ꢁC in humidified
air containing 5% CO2. For subculturing, monolayer cells were
harvested after trypsin/EDTA treatment at 37ꢁC. Cells were used
when confluence had reached 75%. Tested samples were dis-
solved in dimethyl sulphoxide (DMSO). All cell culture material
was obtained from Cambrex BioScience (Copenhagen, Den-
mark). All chemicals were obtained from Sigma/Aldrich, USA,
except mentioned. All experiments were repeated three times,
unless mentioned.
Cytotoxicity assay. Cytotoxicity of tested samples was
measured using the MTT cell viability assay. MTT (3-[4,5-
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet